Sort
15,842 grants matching “pancreatic cancer”
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,471Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2020 · CA
Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.
$677,442Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2021 · CA
Interstitial Chemophototherapy as an Intervention in Locally Advanced Pancreatic Cancer
$677,176Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2025 · CA
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
$677,025Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
Clinical Resources Key Componient Activity
$676,721R Hal Scofield · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2013 · GM
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.
$676,225Hak Soo Choi · Massachusetts General Hospital · R01 · FY2017 · EB
A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
$676,081Jennifer Bailey Lundberg · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA
CCR FACS Core Laboratory
$675,994Barbara Taylor · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution
$675,419Ryan T Kelly · Battelle Pacific Northwest Laboratories · R33 · FY2017 · CA
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications
$675,144Michael John Evans · University Of California, San Francisco · R01 · FY2021 · EB
Targeted degradation of RNAs by using small molecules
$675,077Matthew D Disney · Scripps Florida · R01 · FY2021 · CA
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
$674,985Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2020 · CA
Overcoming anti-PEG immunity to restore prolonged circulation and efficacy of PEGylated therapeutics
$674,568Samuel Lai · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
$674,537Timothy A Marlowe · Faknostics, Llc · R42 · FY2021 · CA
Prospective immune profiling using methylation markers and pancreatic cancer risk
$674,455Dominique S Michaud · Tufts University Boston · R01 · FY2018 · CA
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT)
$674,438Bechien Wu · Kaiser Foundation Research Institute · R01 · FY2019 · CA
Signal Transduction by Tyrosine Phosphorylation
$674,327Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2016 · CA
Signal Transduction by Tyrosine Phosphorylation
$674,327Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2017 · CA
Signal Transduction by Tyrosine Phosphorylation
$674,327Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2018 · CA
A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer following frontline FOLFIRINOX
$674,275Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2025 · CA
A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer following frontline FOLFIRINOX
$674,275Juan Fernando Vera · Marker Therapeutics, Inc. · R44 · FY2024 · CA
Large scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports
$674,025Meliha Yetisgen · University Of Washington · R01 · FY2021 · CA
Magnetic Resonance Fingerprinting of Tumor Vascular Perfusion and Acidosis
$673,812Christopher A Flask · Case Western Reserve University · R01 · FY2023 · CA
Early Diagnosis of Pancreatic Cancer
$673,656Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2010 · CA
Early Diagnosis of Pancreatic Cancer
$673,653Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2006 · CA